Schedule 13D ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2016-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,055,534
- Percent of class
- 20.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-079089
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Feb 04, 2016
- Reporting period
- Feb 04, 2016
- Description
- Schedule 13D beneficial ownership